Recent News

• 12.10.2025 - HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
• 11.26.2025 - HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
• 11.13.2025 - HeartBeam Reports Third Quarter 2025 Results
• 10.30.2025 - HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
• 10.28.2025 - HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
• 09.08.2025 - HeartBeam’s Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias
• 08.28.2025 - HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
• 08.13.2025 - HeartBeam Reports Second Quarter 2025 Results

Recent Filings

• 11.21.2025 - 8-K Current report
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities